Basic Information
Atimos Pressurised Inhalation Solution 12mcg/ inhalation
AEROSOL, METERED
Regulatory Information
SIN13761P
February 3, 2010
Prescription Only
Therapeutic
RESPIRATORY (INHALATION)
August 10, 2023
May 30, 2025
XR03AC13
Company Information
Active Ingredients
Strength: 0.012mg/inhalation
Detailed Information
Contraindications
**CONTRAINDICATIONS** Hypersensitivity to the active ingredient, or to any of the excipients, or any other chemically related substances. Tachyarrhythmiae, 3rd grade atrioventricular block, idiopathic hypertrophic subaortal stenosis, hypertrophic obstructive cardiomyopathy, idiopathic or drug-induced long-QT syndrome (QTc > 0.44 seconds), severe hyperthyroidism. Generally contraindicated during pregnancy and lactation (see also “Special Warnings” – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).
Indication Information
**THERAPEUTIC INDICATIONS** 1. Prophylaxis and treatment of bronchoconstriction in patients with asthma as an add-on to inhaled glucocorticosteroid treatment. 2. Prophylaxis of bronchospasm induced by inhaled allergens, cold air, or exercise.